Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Exchange Rate Effect (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Exchange Rate Effect for 6 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 6.98% year-over-year to $1.4 million, compared with a TTM value of $109000.0 through Dec 2025, down 97.59%, and an annual FY2025 reading of $109000.0, down 97.59% over the prior year.
  • Exchange Rate Effect was $1.4 million for Q4 2025 at Cytek Biosciences, up from $846000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $2.3 million in Q2 2024 and bottomed at -$1.4 million in Q2 2022.
  • Average Exchange Rate Effect over 5 years is $100400.0, with a median of $61000.0 recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 2233.33% in 2022, while the deepest fall reached 1034.0% in 2022.
  • Year by year, Exchange Rate Effect stood at $678000.0 in 2021, then crashed by 247.79% to -$1.0 million in 2022, then grew by 17.86% to -$823000.0 in 2023, then surged by 284.45% to $1.5 million in 2024, then dropped by 6.98% to $1.4 million in 2025.
  • Business Quant data shows Exchange Rate Effect for CTKB at $1.4 million in Q4 2025, $846000.0 in Q3 2025, and -$921000.0 in Q2 2025.